Clinical Trial Update: A Study in Pediatric Patients With Cystic Fibrosis Lung Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in pediatric cystic fibrosis lung disease sponsored by Merck Sharp & Dohme LLC has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED